Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase
暂无分享,去创建一个
K. Ohno | T. Ushida | H. Koike | Y. Nishida | B. Ohkawara | K. Kimata | S. Imagama | T. Shinomura | Li-sheng Zhuo